We are live on
!
Find out more
BC
Blackhill Capital Portfolio holdings
AUM
$1.94B
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter
Est. Return
-3.5%
1 Year Est. Return
+18.09%
3 Year Est. Return
+164.47%
5 Year Est. Return
+136.25%
10 Year Est. Return
+688.12%
AUM
$1.1B
AUM Growth
-$49.5M
(-4.3%)
Cap. Flow
+$3.11M
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
85.23%
Holding
56
New
–
Increased
4
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$3.96M |
| 2 |
AbbVie
ABBV
|
+$473K |
| 3 |
Williams-Sonoma
WSM
|
+$374K |
| 4 |
Tootsie Roll Industries
TR
|
+$1.07K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.47M |
| 2 |
Zoetis
ZTS
|
+$144K |
| 3 |
Pfizer
PFE
|
+$44.3K |
| 4 |
Johnson & Johnson
JNJ
|
+$33.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 59.13% |
| 2 | Healthcare | 26.65% |
| 3 | Technology | 5.19% |
| 4 | Communication Services | 3.5% |
| 5 | Consumer Staples | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Williams-Sonoma
WSM
$29.5B
| $643M | 58.58% |
8,054,340
+4,400
| +0.1% | +$374K |
|
|
2
Zoetis
ZTS
$31.1B
| $43.4M | 3.95% |
232,739
-827
| -0.4% | -$144K |
|
3
Apple
AAPL
$4.45T
| $37.5M | 3.42% |
273,800
| – | – |
|
4
Abbott
ABT
$190B
| $37.4M | 3.41% |
322,830
| – | – |
|
5
Eli Lilly
LLY
$1.08T
| $34M | 3.1% |
148,023
| – | – |
|
6
Walt Disney
DIS
$179B
| $33.3M | 3.03% |
189,300
| – | – |
|
7
Bristol-Myers Squibb
BMY
$130B
| $28.5M | 2.6% |
426,964
| – | – |
|
|
8
AbbVie
ABBV
$442B
| $28.4M | 2.58% |
251,760
+4,200
| +2% | +$473K |
|
|
9
Johnson & Johnson
JNJ
$626B
| $25.7M | 2.34% |
156,030
-200
| -0.1% | -$33.1K |
|
|
10
Elanco Animal Health
ELAN
$11.4B
| $24.3M | 2.21% |
699,171
+120,000
| +21% | +$3.96M |
|
|
11
Merck
MRK
$322B
| $21.9M | 1.99% |
281,250
-19,788
| -7% | -$1.47M |
|
12
Microsoft
MSFT
$3.74T
| $19.2M | 1.75% |
70,850
| – | – |
|
13
Zimmer Biomet
ZBH
$18.5B
| $15.7M | 1.43% |
100,322
| – | – |
|
14
Caterpillar
CAT
$388B
| $13.1M | 1.19% |
60,000
| – | – |
|
|
15
Pfizer
PFE
$152B
| $12.8M | 1.17% |
327,101
-1,138
| -0.3% | -$44.3K |
|
16
Kimberly-Clark
KMB
$36.1B
| $11.4M | 1.04% |
85,000
| – | – |
|
17
Baxter International
BAX
$14.3B
| $9.19M | 0.84% |
114,200
| – | – |
|
18
Mastercard
MA
$492B
| $7.3M | 0.67% |
20,000
| – | – |
|
19
Procter & Gamble
PG
$338B
| $6.05M | 0.55% |
44,871
| – | – |
|
20
Cigna
CI
$72.4B
| $5.83M | 0.53% |
24,587
| – | – |
|
21
Berkshire Hathaway Class B
BRK.B
$1.11T
| $5.03M | 0.46% |
18,108
| – | – |
|
22
Amazon
AMZN
$2.94T
| $4.5M | 0.41% |
26,160
| – | – |
|
23
Enterprise Products Partners
EPD
$81.8B
| $3.61M | 0.33% |
149,570
| – | – |
|
24
Medtronic
MDT
$116B
| $3M | 0.27% |
24,177
| – | – |
|
|
MMP
25
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.68M | 0.24% |
54,800
| – | – |
|
Similar funds
FFH
OCM
AAA
FC
HC
NIM
CC
DCM
Blackhill Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Blackhill Capital held 56 positions worth $1.1B, down 4.3% from $1.15B the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 0%. Blackhill Capital opened no new positions and made no exits, leaving the 56-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 59% of assets, down from 63% a quarter earlier, followed by Healthcare and Technology.
- Blackhill Capital added most to Elanco Animal Health in Q2 2021, an estimated $3.96M increase.
- Blackhill Capital's biggest Q2 2021 reduction was Merck, cutting an estimated $1.47M.
- Blackhill Capital's ten largest holdings make up 85% of its $1.1B portfolio in Q2 2021.
- Blackhill Capital opened 0 new positions and closed 0 in Q2 2021.
- Blackhill Capital's portfolio value fell 4.3% quarter-over-quarter to $1.1B.
Based on Blackhill Capital's 13F filing for Q2 2021, filed 13 Aug 2021.